As Health Secretary Robert F. Kennedy Jr. wants to loosen access to peptides, people who have taken the experimental substances report migraines, eye pain and fatigue.

The Center for Science in the Public Interest respectfully submits these comments regarding the Food and Drug Administration’s draft guidance titled “Demonstrating Substantial Evidence of Effectivenes...

CSPI urges the Senate to block Heidi Overton’s FDA nomination amid concerns about vaccine misinformation and anti-reproductive health stances.

CSPI President Peter Lurie argues Nicole Saphier is unfit to serve as Surgeon General, citing investments in Philip Morris and other health-damaging industries.

This Viewpoint summarizes the ways in which federal health agencies and state-level safeguards work in parallel to ensure public health and highlights how 3 recent Supreme Court rulings have reduced t...

For nearly 70 years, food and beverage companies have been able to decide on their own that a new ingredient is safe and put it on the market without informing the Food and Drug Administration. But a ...

This Viewpoint summarizes the ways in which federal health agencies and state-level safeguards work in parallel to ensure public health and highlights how 3 recent Supreme Court rulings have reduced t...

This Viewpoint summarizes the ways in which federal health agencies and state-level safeguards work in parallel to ensure public health and highlights how 3 recent Supreme Court rulings have reduced t...

That panel will meet to weigh whether the agency should allow Americans to have broader access to seven injectable peptides previously restricted over potential safety concerns.

Prasad and Makary disagree that some may believe this move to just one pivotal trial shows the FDA relaxing its standards.

The chains of amino acids are increasingly marketed for antiaging and health benefits. However, medical experts say many of those claims have not yet been fully tested.

Unlikely lifestyle paragon RFK Jr.’s leadership at HHS drives national policy not by science, but by the Secretary’s personal beliefs.

The weight loss drug retatrutide has been touted as "Ozempic on steroids." It's still in clinical trials and not approved by the FDA, but a CBS News investigation found that hasn't stopped doctors fro...

YouTube video by U.S. Food and Drug Administration

Thank you for the opportunity to share our perspective on the Commissioner’s National Priority Review (CNPV) pilot program in written comments and at the public meeting. The undersigned individuals wr...

This Viewpoint considers the US Food and Drug Administration’s track record for transparency and urges the agency to fortify transparency efforts.

On Jan 7, 2026, the US Departments of Health and Human Services (HHS) and Agriculture (USDA) published the 10th edition of the Dietary Guidelines for Americans (DGA).1 The new DGA are consequential, s...

Lawmakers requested the report after a 2023 ProPublica and Pittsburgh Post-Gazette investigation revealed that the FDA had received hundreds of complaints over many years about defective breathing mac...

Why are so many Americans turning to health alternatives today?